Rybelsus (Oral Semaglutide)
$180.00Rybelsus is the first and only oral GLP-1 receptor agonist tablet, providing powerful weight loss and blood sugar control without the need for needles or injections.
Available: 3mg, 7mg, 14mg
In Stock (90 available)
Why Choose Rybelsus?
No needles required! Enjoy the full metabolic advantages of semaglutide in an easy-to-take daily morning tablet.
How to Use
Take once daily upon waking with a sip of plain water (no more than 120 mL). Wait at least 30 minutes before eating, drinking, or taking other oral medications.
Safety Information
Strictly adhere to the morning fasting instructions for optimal absorption across the stomach lining.
Potential Side Effects
Mild nausea, abdominal discomfort, decreased appetite, and diarrhea during initial titration.
Product Facts
| Generic Name | Semaglutide (Oral Formulation with SNAC) |
| Brand Name | Rybelsus |
| Type of Medication | Oral GLP-1 Receptor Agonist |
| FDA Approval Date | September 20, 2019 |
| Indications | Adjunct to diet and exercise to improve glycemic control and assist sustained metabolic weight management. |
| Dosage Forms | Oral tablets (3 mg, 7 mg, 14 mg) |
| Administration | Once daily in the morning on an empty stomach |
| Special Precautions | Must be swallowed whole with no more than 4 oz (120 mL) of water at least 30 minutes before any food, beverage, or other medications. |
| Drug Interactions | Absorption requires strict adherence to fasting conditions; concurrent oral intake impairs absorption. |
| Use in Specific Populations | Not recommended during pregnancy or while breastfeeding. |
| Prescription | Prescription Required |
| Manufacturer | Novo Nordisk |
How to Buy
Select your tablet strength (3mg starter, 7mg maintenance, or 14mg target) and proceed to secure checkout.